Related Articles |
Price-Utility Evaluation of Electro acupuncture Evaluating Non-steroidal anti-inflammatory medicine (NSAIDs) within the remedy of Power Low Again Ache.
J Acupunct Meridian Stud. 2018 Feb 02;:
Authors: Toroski M, Nikfar S, Mojahedian MM, Ayati MH
Summary
INTRODUCTION: and Goal: Power Low Again Ache (CLBP) is among the many most typical and vital causes for visiting a backbone surgeon by sufferers; it’s the second reason for visiting a health care provider. Low again ache may cause appreciable struggling and is a serious monetary burden within the society. There are various completely different strategies accessible for the remedy of CLBP. This examine aimed to check the cost-utility of Electro-acupuncture (EA) and NSAIDs, as two frequent remedy strategies for sufferers with CLBP.
METHODS: This examine was carried out on 100 sufferers affected by Power Low Again Ache. Instances have been randomly chosen from sufferers referring to 2 hospitals and 4 acupuncture clinics in Tehran. Forty one (41) sufferers acquired EA and 59 sufferers have been prescribed NSAIDs. The EuroQol EQ-5D questionnaire was used to calculate High quality-Adjusted Life-12 months (QALY). For calculating the overall value of the 2 remedy strategies, head to head interview with sufferers was carried out by the researchers (utilizing particular fundamental literature questionnaire), neurologists, and backbone surgeons. The examine perspective was social (direct and oblique prices calculated).
RESULTS: The imply age for EA group was 41±2.three years and for NSAIDs group it was 38.zero± four.four. The typical of the utility of sufferers underneath remedy by EA and NSAIDs was estimated as zero.70 and zero.627, respectively. The distinction in utility between the 2 teams was important (p?zero.05). The entire value of EA and NSAIDs was estimated as 461.48±57.eight$ and 497.77±85.2$ for one yr (2016), respectively, which was additionally important (p?zero.05).
CONCLUSION: The outcomes point out a major distinction between EA and NSAIDs in instances of each utility and whole value. The findings show that EA is more cost effective than NSAIDs, as subsequently could be thought of instead remedy for CLBP, with affordable cost-utility.
PMID: 29436371 [PubMed – as supplied by publisher]